Galderma Laboratories, LP, has announced the publication of the long-term efficacy and safety results of a 1-year, open-label, non-comparative study

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

New User Registration
* Please indicate that you agree to the Terms of Service
*Required field